27 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
obligations; compliance with anti-corruption, sanctions and trade control laws; environmental risks; and the impact of ESG issues;
the impact of the state
8-K
EX-99.1
4b3tk6v el
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
85fmpah3le2cnm qx
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
d4kgfvw h9axc
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
75xdgk1bks5
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-99.1
rz72 yir8g8kr2
3 May 22
Results of Operations and Financial Condition
7:01am